Application

18011856 · HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413 (TAU-pS413)

Filed 2022-12-21 · Granted The official file ↗ · Art unit 1675 · Examiner Chang Yu Wang Hard · CPC C07K 16/18 · Merck Sharp & Dohme LLC · MERCK

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

31.0 mo

to disposition 44.6 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.